Casdin Capital »

Contineum Therapeutics shares owned by Casdin Capital

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Casdin Capital from 13F filings

Historical chart of Casdin Capital investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Casdin Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.7M 297k 19.14
2024-06-30 $5.2M 297k 17.61